Branimir I. Šikić - Publications, H-index & Citations

Branimir I. Šikić

Stanford University

65H指数

353论文数

2.2W被引数

收录论文 57

发表时间

Editorial Expression of Concern: Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition 编辑关注声明：基础和药物诱导的微管聚合水平降低是卵巢癌细胞对紫杉烷类药物耐药的标志，并且与上皮-间质转化相关。

British Journal of Cancer

IF6.8

2025-10-06

PREAI

George E. Duran; Yan C. Wang; François Moisan; E. Brian Francisco; Branimir I. Sikic

Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2023-09-17

OAAI

Kovac, Margareta Pernar; Tadic, Vanja; Kralj, Juran; Duran, George E.; Stefanelli, Alessia; Polancec, Darija Stupin; Dabelic, Sanja; Bacic, Niko; Tomicic, Maja T.; Heffeter, Petra; Sikic, Branimir I.; Brozovic, Anamaria

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies

BLOOD ADVANCES

IF7.1

2020-05-07

OAAI

Ansell, Stephen M.; Flinn, Ian; Taylor, Matthew H.; Sikic, Branimir, I; Brody, Joshua; Nemunaitis, John; Feldman, Andrew; Hawthorne, Thomas R.; Rawls, Tracey; Keler, Tibor; Yellin, Michael J.

Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition

BRITISH JOURNAL OF CANCER

IF6.8

2017-04-11

OAAI

Duran, George E.; Wang, Yan C.; Moisan, Francois; Francisco, E. Brian; Sikic, Branimir I.

Chromatin-Remodeling Complex SWI/SNF Controls Multidrug Resistance by Transcriptionally Regulating the Drug Efflux Pump ABCB1

CANCER RESEARCH

IF16.6

2016-10-02

OAAI

Dubey, Ramin; Lebensohn, Andres M.; Bahrami-Nejad, Zahra; Marceau, Caleb; Champion, Magali; Gevaert, Olivier; Sikic, Branimir I.; Carette, Jan E.; Rohatgi, Rajat

A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors

INVESTIGATIONAL NEW DRUGS

IF2.7

2016-07-16

OAAI

Rosen, Lee S.; LoRusso, Patricia; Ma, Wen Wee; Goldman, Jonathan W.; Weise, Amy; Colevas, A. Dimitrios; Adjei, Alex; Yazji, Salim; Shen, Angela; Johnston, Stuart; Hsieh, Hsin-Ju; Chan, Iris T.; Sikic, Branimir I.

Cabazitaxel is more active than first generation taxanes in ABCB1(+) cell lines due to its higher intracellular accumulation and reduction in ATPase stimulation

CANCER RESEARCH

IF16.6

2016-07-15

PREAI

Duran, George E.; Weitz, Dietmar; Semiond, Dorothee; Gianolio, Diego; Mace, Sandrine; Sikic, Branimir I.

The anti-CD47 antibody Hu5F9-G4 activates macrophages and inhibits ovarian cancer xenografts, alone and in combination with chemotherapy or immunotherapy

CANCER RESEARCH

IF16.6

2016-07-15

PREAI

Kathawala, Rishil J.; Mundy, David C.; Duran, George E.; Volkmer, Jens-Peter; Kao, Kevin S.; Wang, Yan C.; Bellary, Aditi; Weissman, Irving L.; Sikic, Branimir I.

The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells

MOLECULAR ONCOLOGY

IF4.5

2015-05-16

OAAI

Brozovic, Anamaria; Duran, George E.; Wang, Yan C.; Francisco, E. Brian; Sikic, Branimir I.

Mechanisms of Resistance to Cabazitaxel

MOLECULAR CANCER THERAPEUTICS

IF5.5

2015-01-13

OAAI

Duran, George E.; Wang, Yan C.; Francisco, E. Brian; Rose, John C.; Martinez, Francisco J.; Coller, John; Brassard, Diana; Vrignaud, Patricia; Sikic, Branimir I.

Resistance to cabazitaxel is associated with ABCB1/P-glycoprotein activation, alterations in β-tubulin content and dynamics, reduced BRCA1, and a mesenchymal phenotype in MCF-7 human breast cancer variants

CANCER RESEARCH

IF16.6

2014-10-01

PREAI

Duran, George E.; Wang, Yan C.; Francisco, E. Brian; Martinez, Francisco J.; Sikic, Branimir I.

BAL101553 (prodrug of BAL27862): A unique microtubule destabilizer active against drug refractory breast cancers alone and in combination with trastuzumab

CANCER RESEARCH

IF16.6

2014-10-01

PREAI

Bachmann, Felix; Burger, Karin; Duran, George E.; Sikic, Branimir I.; Lane, Heidi A.

Proffered Paper: Overcoming immune evasion in ovarian and breast cancer with anti-CD47 antibody blockade: A novel class of immune therapy

EUROPEAN JOURNAL OF CANCER

IF7.1

2014-07-01

PREAI

Volkmer, A. K.; Willingham, S. B.; Tseng, S. R.; Ho, P. Y.; Volkmer, J. P.; Sikic, B. I.; Majeti, R.; Weissman, I. L.

Identification of ovarian cancer driver genes by using module network integration of multi-omics data

INTERFACE FOCUS

IF4

2014-06-06

OAAI

Gevaert, Olivier; Villalobos, Victor; Sikic, Branimir I.; Plevritis, Sylvia K.

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers

MOLECULAR ONCOLOGY

IF4.5

2014-04-18

OAAI

Moisan, Francois; Francisco, Edgar B.; Brozovic, Anamaria; Duran, George E.; Wang, Yan C.; Chaturvedi, Shalini; Seetharam, Shobha; Snyder, Linda A.; Doshi, Parul; Sikic, Branimir I.

Identification of ovarian cancer driver genes by using module network integration of multi-omics data

INTERFACE FOCUS

IF4

2013-08-06

OAAI

Gevaert, Olivier; Villalobos, Victor; Sikic, Branimir I.; Plevritis, Sylvia K.

Enhancement of paclitaxel and carboplatin therapy by CCL2 blockade in ovarian cancers

CANCER RESEARCH

IF16.6

2012-04-01

PREAI

Moisan, Francois; Francisco, Edgar B.; Brozovic, Anamaria; Duran, George E.; Wang, Yan C.; Seetharam, Shobha; Snyder, Linda A.; Doshi, Parul; Sikic, Branimir I.

Comprehensive miRNA profiling of taxane-resistant human breast and ovarian cancer cell lines using the SmartChip real-time PCR system

CANCER RESEARCH

IF16.6

2012-04-01

PREAI

Duran, George E.; Wang, Cindy Y.; Francisco, E. Brian; Wong, Kee; Robinson, Nicole; Sikic, Branimir I.

Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors

INVESTIGATIONAL NEW DRUGS

IF2.7

2012-02-14

OAAI

Kunz, Pamela L.; He, Aiwu R.; Colevas, A. Dimitrios; Pishvaian, Michael J.; Hwang, Jimmy J.; Clemens, Pamela L.; Messina, Marianne; Kaleta, Remigiusz; Abrahao, Fernanda; Sikic, Branimir I.; Marshall, John L.

A first-in-human phase 1 study to evaluate the MEK1/2 inhibitor GDC-0973 administered daily in patients with advanced solid tumors

CANCER RESEARCH

IF16.6

2011-04-01

PREAI

Rosen, Lee; LoRusso, Patricia; Ma, Wen Wee; Goldman, Johathan; Weise, Amy; Colevas, A. Dimitrios; Adjei, Alex; Yazji, Salim; Shen, Angela; Johnston, Stuart; Gates, Mary R.; Jones, Cheryl; Musib, Luna; De Crespigny, Alex; Chan, Iris; Sikic, Branimir

研究方向